GrowingStockReport.com

VIVUS Inc. (NASDAQ:VVUS) and Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) Added to Growing Stock Report's NASDAQ Decliners Watch List.

 

New York, NY -- (ReleaseWire) -- 06/13/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding VIVUS Inc. (NASDAQ:VVUS) and Astex Pharmaceuticals, Inc. (NASDAQ:ASTX).

VIVUS Inc. (NASDAQ:VVUS) a company that engages in developing and commercializing therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health closed down in its previous session (-4.04%) on 1,760,615 shares traded after VIVUS, Inc. announced that management will present an overview of the company at Upcoming Investor Conference. VIVUS Inc. (NASDAQ:VVUS) is currently down (-54.66%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about VIVUS Inc. (NASDAQ:VVUS)

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) a company that engages in the discovery and development of small molecule therapeutics with a focus on oncology and hematology using its fragment-based drug discovery platform, Pyramid closed down in its previous session (-4.27%) on 944,317 shares traded. Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) is currently down (-35.4%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com